Posts
($LTRN) Lantern Just Released a New Corporate Presentation. One Slide Stood Out!
Most people still seem to view Lantern as “the LP-300 company.” Their latest corporate deck suggests management sees the future very differently: 1. LP-300 (Phase 2) 2. LP-184 (multiple planned Phase 1b/2 trials) 3. RADR AI platform 4. withZeta AI research platform What’s interesting is that Lantern describes the goal …
NIXX Potential $2's Near-Term; Changing Value-Perception Among Market Players
**I’ve seen several posts about $NIXX** through the lens of sector potential but after the big news and great movement we’ve seen today I wanted to look at the charts to see if there’s any indicators of what’s next. Is it a “put aside and let it cool off” or …
Heidmar Maritime Holdings (HMR)
Back in HMR as a clear beneficiary of The Orange ShitGibbon's Strait of Hormuz fuckwittery. Shipping rates will rise and HMR has a largely fixed cost base so we will continue to see elevated EPS for this quarter and likely the next making a really good year ahead.
EnSilica (🇬🇧ENSI 🇺🇸 ENSIF): FY26 Trading Update - Record Results Expected!
With these unaudited results and the growing opportunity pipeline I am more confident than ever in my opinion that EnSilica’s share price may exceed £5 / $6.79 by 2030. A potential 5x or more all things going well. Here is professional commentary today from Matt Butlin of Allenby Capital… ’EnSilica …
France Awards Eutelsat €138 Million Contract to Provide Secure Communications
$UNCY (Unicycive Therapeutics) – PDUFA Date June 29: High-Probability Catalyst + Short Squeeze Setup
Unicycive Therapeutics ($UNCY - $7.87 - Mark cap: 210M) is a late-stage biotech focused on kidney disease treatments. Its lead product, **Oxylanthanum Carbonate (OLC)**, is a next-generation phosphate binder for chronic kidney disease (CKD) patients on dialysis. OLC is designed to reduce pill burden while maintaining phosphate control, potentially improving …
BREAKING: Nvidia partners with Harvard spinout Zapata Quantum ($ZPTA) to automate quantum algorithm benchmarking in Boston
Nvidia is expanding its quantum partnerships in the Boston area and has added Zapata Quantum (ticker: ZPTA), a Harvard spinout, to the roster. According to Boston Business Journal, the collaboration focuses on **automating quantum algorithm benchmarking**, which should help accelerate drug discovery and other real-world hybrid quantum-classical applications. Quick context …
The Lounge
Talk about your daily plays, ideas and strategies that do not warrant an actual post. This is the place to request buy/sell advice from the community. Remember to keep it civil. Trade responsibly.
Ault-affiliated investors report a sizable stake in YY Group Holding Ltd. Milton C. Ault III is reported as beneficial owner of 7,348,000 Class A ordinary shares, representing 7.7% of the company
Rich Guy Buys More Shares + Android Robots + Nvidia AI + Reverse Split = Peak Microcap Degeneracy? Not financial advice. I may have consumed lead paint chips as a child and grew up behind a chemical plant. So let me get this straight: Rich guy who controls/owns a large …
$POLA Repeating 25% Range Play and Possible Breakout
Just wanted to draw your attention to some interesting price action because it looks constructive and could be setting up for a bigger move. $POLA, nano Float, haven’t found any news. Today it basically started acting like it was making a range rotation and setting up for a possible follow-on …